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Clinical / Scientific note
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Firearm projectiles have been described, albeit rarely, 
as a cause of lead toxicity. The usual route of lead expo-
sure is oral ingestion, but toxicity secondary to retained 
bullet fragments has been well documented1. Switz et 
al. described the first case in 1976 – a bullet was lodged 
in a patient’s left ankle and gastrointestinal symptoms 
emerged forty years after the wound2. Since then sever-
al reports followed, including one by Goodheart et al.3, 
in 1999, in which the authors reported 25 patients with 
lead intoxication secondary to intentional petrol sniffing, 
among whom 8 presented with chorea, though the most 
common neurological complication was altered mental 
state, observed in all subjects. The major clinical manifes-
tations of lead toxicity are gastrointestinal, hematologi-
cal and neurological, namely abdominal cramps, anorex-
ia, nausea, vomiting, constipation, anemia, headache, pe-
ripheral neuropathy and encephalopathy4. This is charac-
terized by delirium, seizures, somnolence, and even coma. 
Joint and muscle pain and nephropathy may also be part 
of the clinical picture5.
We herein describe an interesting case, where choreo-
athetosis was attributed to lead toxicity due to retained 
bullet fragments.
CASE
A 42-year-old right-handed man was shot in 1987 at the age 
of 23. He had been a drug addict since the age of 14 – he had 
used marijuana and inhaled cocaine, but denied intravenous drug 
use. He was shot in the left side of the abdomen, left shoulder 
and right thigh. At that time, he had undergone emergency sur-
gery – there was no injury to internal organs, but one of the 
bullets could not be successfully removed because its location 
in the lumbar spinal column – in close proximity to the spinal 
cord – was considered too risky. The patient was discharged a 
week after the surgery. 
He remained asymptomatic until February 1994, when he 
started complaining of frequent abdominal cramps, nausea, 
vomiting and constipation. On that occasion he was referred to 
the Orthopedics Clinic of our hospital. On physical examination, 
he was pale, the abdomen was diffusely tender to palpation, 
but there were no signs of peritonitis. Neurological examination 
was normal. His blood exams showed normochromic normocyt-
ic anemia and blood lead levels were in the toxic range (112 µg/
dL), which was attributed to the retained bullet. He was diag-
nosed with lead toxicity and underwent chelation with dimer-
caprol and EDTA (ethylenediaminetetracetic acid). One month 
later, since the blood lead levels remained high (65 µg/dL), che-
Fig 1. Neuroimaging results. (A) CT 
demonstrates bilateral and symmet-
ric pallidal calcifications. (B) Coronal 
T2-weighted image from MR exam de-
picts volumetric reduction of both pu-
tamen and caudate nuclei, presenting 
hyperintensity in a bilateral and sym-
metric fashion.
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lation with EDTA was administered again, followed by an unsuc-
cessful attempt to surgically remove the bullet from the spine. 
There was improvement of the abdominal cramps, but within 
a few weeks of the procedure, the patient noticed involuntary 
movements of the hands, trunk and feet. He was then admitted 
to the Neurologic Clinic for diagnostic evaluation. 
The patient is the first child of non-consanguineous par-
ents. His family history is negative for neurological diseases. 
On neurological examination, there were generalized, partial-
ly-suppressible choreoathetoid movements involving the face 
and proximal limbs, in addition to the toes and fingers. He had 
a dystonic posture on the right upper limb. His muscle strength, 
deep tendon reflexes and cognitive function were normal. There 
was rigidity in the four limbs and plantar reflexes were flexor.
Blood exams were unremarkable, including liver and thyroid 
function and rheumatologic tests. HIV antibody testing was neg-
ative, as well as hepatitis serology. Serum and urinary (24 hour 
collection) copper and serum cerulopasmin were within normal 
limits. Huntington disease genetic testing was negative. Electro-
neuromyography of the four limbs was normal. Cerebrospinal 
fluid (CSF) analysis revealed normal protein and glucose levels, 
negative VDRL, no red blood cells and 3 leucocytes. Computed 
tomography performed in 1996 showed bilateral and symmetric 
pallidal calcifications and a slight hypoattenuation in both pu-
tamen and caudate nuclei. He also underwent brain MRI, which 
demonstrated some volumetric reduction in both caudate and 
lentiform nuclei, associated with bilateral and symmetric T2 hy-
perintensity and T1 hypointensity of these structures (Fig  1). 
Blood lead levels were still increased (69 µg/dL) and another 
course of EDTA was prescribed.
The patient was given chelation therapy with EDTA for four 
months and blood lead levels eventually returned to normal (Fig 
2). Abnormal movements persisted and were only controlled 
with neuroleptics. Patient is currently taking haloperidol 7 mg 
daily. Since the beginning of its administration, the patient tried 
to withdraw the drug on several occasions, resulting in signifi-
cant worsening of the choreoathetosis.
DISCUSSION
Although it is not common in clinical practice, move-
ment disorders can occur following exposure to several 
chemical substances, such as heavy metals, pesticides and 
organic solvents. Goldings et al. in 1982 described the case 
of a 15 year-old boy who inhaled gasoline and developed 
chorea, myoclonus and ataxia due to lead encephalopa-
thy6. Goodheart et al. in 1999 also reported patients with 
petrol sniffing history, lead toxicity and chorea3, but to 
our knowledge no cases of choreoathetosis secondary to 
lead toxicity because of a retained bullet have been pub-
lished to date.
In the case herein described neurological symptoms 
consisted of choreoathetosis and were ascribed to lead 
toxicity due to a retained bullet lodged in the spinal col-
umn for the past 7 years. But could the patient develop 
lead toxicity after such a long interval from the gunshot 
wound? It has been demonstrated that blood lead levels 
tend to increase with time after injury in patients with 
projectile retention7.Onset of symptoms from the initial 
gunshot wound has been reported from 2 days up to 52 
years1. 
The pathophysiology of lead absorption from retained 
bullets is still unclear, but there seems to be a correlation 
between bullet location and lead toxicity7. Synovial and 
bony interfaces and contact with pleural and CSF have 
been associated with elevated absorption rates1. As the 
onset of symptoms may be insidious and the asymptom-
atic interval may be prolonged, a high index of suspicion 
is required to diagnose lead toxicity8. 
In 1997 Centers for Disease Control and Prevention 
defined elevated blood lead levels for children as exceed-
ing 10 µg/dL9. In adults, severe lead toxicity is associated 
with blood lead concentrations of 100 µg/dLl or more10. 
This patient had lead levels of up to 112 µg/dL, consistent 
with severe toxicity. 
CT in this case disclosed pallidal calcifications, bilat-
eral and symmetric, which is a relatively common finding 
in patients over age 4011. However, the patient was only 32 
years old by the time the first CT was performed, which 
raises the possibility that these calcifications could be as-
sociated to lead intoxication. Calcifications are commonly 
described in this condition, especially in the chronic form 
(as is the case described here). They are usually linear in 
the subcortical area and they can be seen also in the cer-
ebellum and basal ganglia12. 
MR imaging showed in detail striatal lesions which 
are probably the substrate for the choreoathetoid move-
ments. There was a clear decrease in volume of the cau-
date nuclei and also of the putamen, associated to signal 
abnormalities that are unspecific, but associated to the 
Fig 2. Decrease of patient’s blood lead levels (µg/dL) after prescrip-
tion of chelation therapy.
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atrophy of these structures, can be related to gliosis and 
end-stage changes. The irreversibility of the clinical pic-
ture corroborates the imaging aspects, although revers-
ibility can sometimes be appreciated in this entity, mainly 
in acute forms13. MR findings in lead toxicity are variable, 
including white matter, basal ganglia, insula and thalamus 
involvement13,14 – usually presenting T2-hyperintensity. 
Strictly from an imaging standpoint, differential diagnosis 
in this case includes diseases with basal ganglia involve-
ment, especially Wilson disease, which was excluded after 
other diagnostic tests.
We cannot certify that movement disorders and in-
tracranial lesions were due to the lead toxicity, but the 
temporal course certainly suggests it. There remains a 
possibility that the neurological symptoms were not the 
direct effect of the bullet, but we believe that lead poi-
soning was due to the bullet lodged in the spinal cord and 
direct penetration into the CSF compartment. We came 
to the conclusion that the cause of choreoathetosis was 
lead toxicity considering that other common causes were 
excluded.
In this case there was no regression of the involuntary 
movements despite normalization of blood lead levels. 
After prolonged exposure to lead, effects do not appear 
to be reversible even if blood lead levels are lowered with 
chelation15.
Lead toxicity is a very rare cause of choreoathetosis. 
There must be surveillance for people with retained bul-
lets concerning the possible development of lead toxicity, 
since this is a difficult diagnosis.
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